Used as an intermediate in the synthesis of pharmaceutical agents, particularly in the development of nitroimidazole-based antimicrobial and antiparasitic drugs. Its structure supports activity against anaerobic bacteria and certain protozoa by facilitating electron transport disruption within microbial cells. Commonly employed in research settings for designing derivatives with enhanced bioavailability and targeted action. Also utilized in the preparation of radiolabeled compounds for metabolic studies and imaging applications.